These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38477379)

  • 1. A second case report of medulloblastoma in a patient carrying biallelic pathogenic MUTYH germline variants.
    Cipri S; Del Baldo G; Carai A; Cacchione A; Agolini E; Novelli A; Rossi S; Colafati GS; Boccuto L; Mastronuzzi A
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12968. PubMed ID: 38477379
    [No Abstract]   [Full Text] [Related]  

  • 2. First report of medulloblastoma in a patient with MUTYH-associated polyposis.
    Villy MC; Warcoin M; Filser M; Buecher B; Golmard L; Suybeng V; Schwartz M; Bieche I; Vacher S; Laurence V; Bourdeaut F; Bernier M; Gutman T; Stoppa-Lyonnet D; Masliah-Planchon J; Colas C
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12929. PubMed ID: 37524406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Elongator mutations in Sonic Hedgehog medulloblastoma.
    Waszak SM; Robinson GW; Gudenas BL; Smith KS; Forget A; Kojic M; Garcia-Lopez J; Hadley J; Hamilton KV; Indersie E; Buchhalter I; Kerssemakers J; Jäger N; Sharma T; Rausch T; Kool M; Sturm D; Jones DTW; Vasilyeva A; Tatevossian RG; Neale G; Lombard B; Loew D; Nakitandwe J; Rusch M; Bowers DC; Bendel A; Partap S; Chintagumpala M; Crawford J; Gottardo NG; Smith A; Dufour C; Rutkowski S; Eggen T; Wesenberg F; Kjaerheim K; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Remke M; Puget S; Pajtler KW; Milde T; Witt O; Ryzhova M; Korshunov A; Orr BA; Ellison DW; Brugieres L; Lichter P; Nichols KE; Gajjar A; Wainwright BJ; Ayrault O; Korbel JO; Northcott PA; Pfister SM
    Nature; 2020 Apr; 580(7803):396-401. PubMed ID: 32296180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.
    Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
    J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a.
    Holsten T; Tsiakas K; Kordes U; Bison B; Pietsch T; Rutkowski S; Santer R; Schüller U
    Childs Nerv Syst; 2018 Mar; 34(3):581-584. PubMed ID: 29167993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.
    Pitroski CE; Cossio SL; Koehler-Santos P; Graudenz M; Prolla JC; Ashton-Prolla P
    Int J Colorectal Dis; 2011 Jul; 26(7):841-6. PubMed ID: 21424714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUTYH-associated tumor syndrome: The other face of MAP.
    Magrin L; Fanale D; Brando C; Corsini LR; Randazzo U; Di Piazza M; Gurrera V; Pedone E; Bazan Russo TD; Vieni S; Pantuso G; Russo A; Bazan V
    Oncogene; 2022 Apr; 41(18):2531-2539. PubMed ID: 35422474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline
    Lindsay H; Scollon S; Reuther J; Voicu H; Rednam SP; Lin FY; Fisher KE; Chintagumpala M; Adesina AM; Parsons DW; Plon SE; Roy A
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31624068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Cancer Interrogation of
    Paller CJ; Tukachinsky H; Maertens A; Decker B; Sampson JR; Cheadle JP; Antonarakis ES
    JCO Precis Oncol; 2024 Feb; 8():e2300251. PubMed ID: 38394468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary Origin of
    Xiao F; Li J; Lagniton PNP; Kou SH; Lei H; Tam B; Wang SM
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
    Yanus GA; Akhapkina TA; Ivantsov AO; Preobrazhenskaya EV; Aleksakhina SN; Bizin IV; Sokolenko AP; Mitiushkina NV; Kuligina ES; Suspitsin EN; Venina AR; Holmatov MM; Zaitseva OA; Yatsuk OS; Pashkov DV; Belyaev AM; Togo AV; Imyanitov EN; Iyevleva AG
    Clin Genet; 2018 May; 93(5):1015-1021. PubMed ID: 29406563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
    Brugières L; Pierron G; Chompret A; Paillerets BB; Di Rocco F; Varlet P; Pierre-Kahn A; Caron O; Grill J; Delattre O
    J Med Genet; 2010 Feb; 47(2):142-4. PubMed ID: 19833601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplifying the detection of MUTYH mutations by high resolution melting analysis.
    López-Villar I; Ayala R; Wesselink J; Morillas JD; López E; Marín JC; Díaz-Tasende J; González S; Robles L; Martínez-López J
    BMC Cancer; 2010 Aug; 10():408. PubMed ID: 20687945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.
    Castillejo A; Vargas G; Castillejo MI; Navarro M; Barberá VM; González S; Hernández-Illán E; Brunet J; Ramón y Cajal T; Balmaña J; Oltra S; Iglesias S; Velasco A; Solanes A; Campos O; Sánchez Heras AB; Gallego J; Carrasco E; González Juan D; Segura A; Chirivella I; Juan MJ; Tena I; Lázaro C; Blanco I; Pineda M; Capellá G; Soto JL
    Eur J Cancer; 2014 Sep; 50(13):2241-50. PubMed ID: 24953332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
    Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a New Germline Variant in the MUTYH DNA Glycosylase Gene with Colorectal Adenoma Transformation into Malignancy.
    Mahasneh A; Al-Shaheri FN; BaniHani MN
    Iran Biomed J; 2019 Nov; 23(6):412-22. PubMed ID: 31104418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma.
    Bourdeaut F; Miquel C; Richer W; Grill J; Zerah M; Grison C; Pierron G; Amiel J; Krucker C; Radvanyi F; Brugieres L; Delattre O
    Pediatr Blood Cancer; 2014 Feb; 61(2):383-6. PubMed ID: 24115570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39-year-old male patient.
    Tzoumpa S; Sevenet N; Bejar-Ardiles CL; Villette B; Zumelzu C; Benamouzig R; Caux F; Maubec E
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e327-e329. PubMed ID: 36151995
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives on the implications of carrying putative pathogenic variants in the medulloblastoma predisposition genes ELP1 and GPR161.
    Smith MJ; Woodward ER; Evans DG
    Fam Cancer; 2023 Jul; 22(3):341-344. PubMed ID: 36961676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.